Peter H. Diamandis

Any thoughts on this?

I mean, I don't think people could have predicted this.

Salim, you want to close this out?

I got nothing.

So yeah, I think- Are these the conversations you're having in your executive committee every day?

By the way, I have to point out, you know, this projection by Morgan Stanley is definitely a fundraising tool ahead of the IPO.

You know, Morgan Stanley is one of the banks that's going to profit from this deal.

There's, you know, I'm reading every day on X that...

Players are opting out of SpaceX.

It's overvalued.

They're valuing it at $700 million, not $1.7 trillion.

So we're going to see.

I fundamentally believe in the long-term value of SpaceX.

I just hope retail investors don't get hit in the process.

So while we have Brian, Brian, longevity and biotech, one of my favorite stories.

So first off, congratulations on your recent raise at New Limit.

$435 million to push us towards age reversal.

If you don't mind, tell us, you know, origin story of New Limit and why you and Blake started and what are you guys doing there?

Amazing human trial next year.

And you and Blake put in the first hundred million.